Literature DB >> 11006058

Population frequency distributions of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B in healthy men and women and associations with age, gender, hormonal status, and sex hormone use: the Stanford Five City Project.

C D Gardner1, D L Tribble, D R Young, D Ahn, S P Fortmann.   

Abstract

BACKGROUND: The purpose of this study is to present population-based frequency distribution data for several lipoprotein-related variables and to examine their associations with gender, age, menopausal status, and sex hormone use.
METHODS: High-density lipoprotein cholesterol (HDL-C), HDL(2)-C, HDL(3)-C, apolipoprotein (Apo) A-I, and Apo B were measured in a population-based sample of 1, 027 healthy adults from four California cities who participated in the 1989-1990 survey of the Stanford Five City Project. These data were examined cross-sectionally with sociodemographic and other related variables.
RESULTS: Relative to men, all of the HDL-related parameters-HDL-C, HDL(2)-C, HDL(3)-C, Apo A-I-were significantly higher and Apo B levels were significantly lower among women (P < 0. 001). Menopausal status was not associated with HDL-related parameters, but Apo B levels were higher in post- versus premenopausal women (P < 0.001). Among women, HDL-C and Apo A-I levels were higher in oral contraceptive and estrogen replacement therapy users (P = 0.003). Most of the significant findings remained statistically significant after adjusting for age, body mass index, smoking, energy expenditure, and alcohol intake.
CONCLUSIONS: These population-based data indicate that gender, menopausal status, and the use of sex hormones among women are associated with differential levels of one or more of HDL-C, HDL(2)-C, HDL(3)-C, Apo A-I, and Apo B, independent of age and a broad set of lifestyle factors. Copyright 2000 American Health Foundation and Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11006058     DOI: 10.1006/pmed.2000.0715

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  10 in total

1.  High-density lipoprotein subfractions in normolipidemic individuals without clinical atherosclerosis lipoprotein subfractions in an adult population.

Authors:  Fabio L Sodré; Vera S Castanho; Lucia N Castilho; Silvia de Barros-Mazon; Eliana C de Faria
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

Review 2.  Therapeutic interventions to enhance apolipoprotein A-I-mediated cardioprotection.

Authors:  Michael J Haas; Arshag D Mooradian
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

3.  Serum 2-methoxyestradiol, an estrogen metabolite, is positively associated with serum HDL-C in a population-based sample.

Authors:  Christopher M Masi; Louise C Hawkley; John T Cacioppo
Journal:  Lipids       Date:  2011-08-02       Impact factor: 1.880

4.  ESR1 polymorphism is associated with plasma lipid and apolipoprotein levels in Caucasians of the Rochester Family Heart Study.

Authors:  Kathy L E Klos; Eric Boerwinkle; Robert E Ferrell; Stephen T Turner; Alanna C Morrison
Journal:  J Lipid Res       Date:  2008-04-30       Impact factor: 5.922

Review 5.  Molecular studies on coronary artery disease-a review.

Authors:  A Supriya Simon; T Vijayakumar
Journal:  Indian J Clin Biochem       Date:  2013-02-12

6.  Lipid profiles of persons with paraplegia and tetraplegia: sex differences.

Authors:  Andreas Schmid; Judith Knöebber; Stefan Vogt; Daniel König; Peter Deibert; Dirk Bültermann; Lothar Heinrich; Manfred W Baumstark; Aloys Berg; Max-Jürgen Storch
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

7.  Gender-specific differences in the kinetics of nonfasting TRL, IDL, and LDL apolipoprotein B-100 in men and premenopausal women.

Authors:  Nirupa R Matthan; Susan M Jalbert; P Hugh R Barrett; Gregory G Dolnikowski; Ernst J Schaefer; Alice H Lichtenstein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-24       Impact factor: 8.311

8.  Moderate alcohol consumption and lipoprotein subfractions: a systematic review of intervention and observational studies.

Authors:  Trine L Wilkens; Kaare Tranæs; Jane N Eriksen; Lars O Dragsted
Journal:  Nutr Rev       Date:  2022-04-08       Impact factor: 6.846

9.  Lipid levels and risk of venous thrombosis: results from the MEGA-study.

Authors:  Vânia M Morelli; Willem M Lijfering; Mettine H A Bos; Frits R Rosendaal; Suzanne C Cannegieter
Journal:  Eur J Epidemiol       Date:  2017-05-24       Impact factor: 8.082

10.  Sex hormones affect endothelial lipase-mediated lipid metabolism and atherosclerosis.

Authors:  Chuan Wang; Manabu Niimi; Shuji Kitajima; Fumikazu Matsuhisa; Haizhao Yan; Sijun Dong; Jingyan Liang; Jianglin Fan
Journal:  Lipids Health Dis       Date:  2019-12-23       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.